Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Daiichi Sankyo
Johnson and Johnson
Julphar
US Army
Express Scripts
Farmers Insurance
Chubb
Moodys

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016683

« Back to Dashboard

NDA 016683 describes DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.
Summary for 016683
Tradename:DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare
Ingredient:dextrose; sodium chloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 016683
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 016683 NDA Baxter Healthcare Corporation 0338-0085 0338-0085-03 24 BAG in 1 CARTON (0338-0085-03) > 500 mL in 1 BAG
DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 016683 NDA Baxter Healthcare Corporation 0338-0085 0338-0085-04 14 BAG in 1 CARTON (0338-0085-04) > 1000 mL in 1 BAG

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5GM/100ML;450MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Moodys
Queensland Health
Chubb
Baxter
Dow
Harvard Business School
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot